PMVPPMV Pharmaceuticals, Inc.

PMVP Stock Price, Valuation & Chart | PMV Pharmaceuticals, Inc.

Compare

$1.260-0.03 (-2.33%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology PMVP intrinsic value PMVP calculated fair value vs price

Overview Financials Dividends Ratios

PMVP Historical price chart

PMVP Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization67.20M

PE Ratio-0.85

EPS-1.49

Trading Volume704.23K

Today's High/Low1.29/1.25

Dividend Yield0.00

52 Week High/Low1.88/1.02

Shares Outstanding53.33M

PMVP Financial Statement

PMVP Analyst ratings

PMVP Analysis & performance metrics

PMVP Company profile

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer.…

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing mutant p53 programs, including…

PMVP Management team

Name

Position

Arnold J. Levine Ph.D.CTO

Co-Founder, Independent Director & Member of Scientific Advisory Board

Binh Vu Ph.D.

Senior Vice President of Drug Discovery & CMC

Tim Smith

Senior Vice President and Head of Corporate Development & Investor Relations

Laura De Leon

Vice President & Head of Clinical Operations

Michael CarulliCFO

Chief Financial Officer

Robert Ticktin J.D.COO

General Counsel, Chief Operating Officer & Company Secretary

David H. Mack Ph.D.CEO

Co-Founder, Chief Executive Officer, President & Director

Crystal Zuckerman

Vice President of Human Resources

Name

Position

Arnold J. Levine Ph.D.CTO

Co-Founder, Independent Director & Member of Scientific Advisory Board

Binh Vu Ph.D.

Senior Vice President of Drug Discovery & CMC

Tim Smith

Senior Vice President and Head of Corporate Development & Investor Relations

Laura De Leon

Vice President & Head of Clinical Operations

Michael CarulliCFO

Chief Financial Officer

Robert Ticktin J.D.COO

General Counsel, Chief Operating Officer & Company Secretary

David H. Mack Ph.D.CEO

Co-Founder, Chief Executive Officer, President & Director

Crystal Zuckerman

Vice President of Human Resources

Management Team

Arnold J. Levine Ph.D.CTO

Co-Founder, Independent Director & Member of Scientific Advisory Board

Binh Vu Ph.D.

Senior Vice President of Drug Discovery & CMC

Tim Smith

Senior Vice President and Head of Corporate Development & Investor Relations

Laura De Leon

Vice President & Head of Clinical Operations

Michael CarulliCFO

Chief Financial Officer

Robert Ticktin J.D.COO

General Counsel, Chief Operating Officer & Company Secretary

David H. Mack Ph.D.CEO

Co-Founder, Chief Executive Officer, President & Director

Crystal Zuckerman

Vice President of Human Resources

Management

Arnold J. Levine Ph.D.CTO

Co-Founder, Independent Director & Member of Scientific Advisory Board

Binh Vu Ph.D.

Senior Vice President of Drug Discovery & CMC

Tim Smith

Senior Vice President and Head of Corporate Development & Investor Relations

Laura De Leon

Vice President & Head of Clinical Operations

Michael CarulliCFO

Chief Financial Officer

Robert Ticktin J.D.COO

General Counsel, Chief Operating Officer & Company Secretary

David H. Mack Ph.D.CEO

Co-Founder, Chief Executive Officer, President & Director

Crystal Zuckerman

Vice President of Human Resources

Total 8 executives

PMVP Frequently asked questions

What is PMV Pharmaceuticals, Inc. (PMVP) Stock Price?

Current stock price of PMV Pharmaceuticals, Inc. (PMVP) stock is $1.260. The stock price is -2.33% lower in the session. The intraday range can be seen from this page. Volume of PMV Pharmaceuticals, Inc. (PMVP) stock is 704.23K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the PMV Pharmaceuticals, Inc. (PMVP) stock price going up or down today?

The stock price of PMV Pharmaceuticals, Inc. (PMVP) can change with earnings, company news, and overall market sentiment. PMV Pharmaceuticals, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the PMV Pharmaceuticals, Inc. stock expensive at its current price?

Whether PMV Pharmaceuticals, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for PMVP on this page is -0.85. EPS on this page is -1.49. Compare those figures with peers and growth expectations before deciding if the current PMV Pharmaceuticals, Inc. price is justified.

How has the stock price of PMV Pharmaceuticals, Inc. (PMVP) performed historically?

Historical performance for PMV Pharmaceuticals, Inc. (PMVP) is shown on the price chart on this page. Review multi-period moves alongside volume to see how PMVP reacted to past earnings and market events.

Should I buy PMV Pharmaceuticals, Inc. (PMVP) stock, at this price?

Buying PMV Pharmaceuticals, Inc. (PMVP) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.